Saswata S. Sarkar

1.4k total citations
14 papers, 894 citations indexed

About

Saswata S. Sarkar is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Materials Chemistry. According to data from OpenAlex, Saswata S. Sarkar has authored 14 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 3 papers in Materials Chemistry. Recurrent topics in Saswata S. Sarkar's work include Cardiomyopathy and Myosin Studies (9 papers), Cardiovascular Effects of Exercise (7 papers) and Muscle Physiology and Disorders (6 papers). Saswata S. Sarkar is often cited by papers focused on Cardiomyopathy and Myosin Studies (9 papers), Cardiovascular Effects of Exercise (7 papers) and Muscle Physiology and Disorders (6 papers). Saswata S. Sarkar collaborates with scholars based in United States, India and France. Saswata S. Sarkar's co-authors include James A. Spudich, Kathleen M. Ruppel, Darshan V. Trivedi, Arjun S. Adhikari, Shirley Sutton, Makenna M. Morck, Suman Nag, Margaret S. Sunitha, Robert L. Anderson and Joshua Gorham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Physical Chemistry B.

In The Last Decade

Saswata S. Sarkar

13 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saswata S. Sarkar United States 11 802 457 71 56 49 14 894
Darshan V. Trivedi United States 14 808 1.0× 465 1.0× 71 1.0× 78 1.4× 91 1.9× 18 912
Samantha Beck Previs United States 13 604 0.8× 448 1.0× 17 0.2× 47 0.8× 94 1.9× 20 738
Thomas Kampourakis United Kingdom 14 691 0.9× 462 1.0× 16 0.2× 39 0.7× 45 0.9× 36 776
Viola Kooij Netherlands 11 463 0.6× 319 0.7× 19 0.3× 18 0.3× 38 0.8× 15 600
Osha Roopnarine United States 14 382 0.5× 282 0.6× 11 0.2× 59 1.1× 64 1.3× 21 476
Mathias Gruen Germany 5 522 0.7× 399 0.9× 23 0.3× 39 0.7× 75 1.5× 7 589
Makenna M. Morck United States 5 369 0.5× 257 0.6× 38 0.5× 15 0.3× 15 0.3× 5 477
R. John Solaro United States 7 570 0.7× 404 0.9× 10 0.1× 40 0.7× 24 0.5× 8 676
Carol Butters United States 17 787 1.0× 599 1.3× 11 0.2× 68 1.2× 105 2.1× 20 931
Brett A. Colson United States 14 509 0.6× 405 0.9× 17 0.2× 22 0.4× 61 1.2× 23 661

Countries citing papers authored by Saswata S. Sarkar

Since Specialization
Citations

This map shows the geographic impact of Saswata S. Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saswata S. Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saswata S. Sarkar more than expected).

Fields of papers citing papers by Saswata S. Sarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saswata S. Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saswata S. Sarkar. The network helps show where Saswata S. Sarkar may publish in the future.

Co-authorship network of co-authors of Saswata S. Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Saswata S. Sarkar. A scholar is included among the top collaborators of Saswata S. Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saswata S. Sarkar. Saswata S. Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hartman, James J., Darren T. Hwee, Julien Robert‐Paganin, et al.. (2024). Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy. Nature Cardiovascular Research. 3(8). 1003–1016. 29 indexed citations
2.
Sarkar, Saswata S., Darshan V. Trivedi, Makenna M. Morck, et al.. (2020). The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin. Science Advances. 6(14). eaax0069–eaax0069. 55 indexed citations
3.
Adhikari, Arjun S., Darshan V. Trivedi, Saswata S. Sarkar, et al.. (2019). β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity. Nature Communications. 10(1). 2685–2685. 57 indexed citations
4.
Anderson, Robert L., Darshan V. Trivedi, Saswata S. Sarkar, et al.. (2018). Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers. Proceedings of the National Academy of Sciences. 115(35). E8143–E8152. 262 indexed citations
5.
Kawana, Masataka, Saswata S. Sarkar, Shirley Sutton, Kathleen M. Ruppel, & James A. Spudich. (2017). Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy. Science Advances. 3(2). e1601959–e1601959. 50 indexed citations
6.
Trivedi, Darshan V., Arjun S. Adhikari, Saswata S. Sarkar, Kathleen M. Ruppel, & James A. Spudich. (2017). Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light. Biophysical Reviews. 10(1). 27–48. 111 indexed citations
7.
Nag, Suman, Darshan V. Trivedi, Saswata S. Sarkar, et al.. (2017). The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nature Structural & Molecular Biology. 24(6). 525–533. 148 indexed citations
8.
Adhikari, Arjun S., Kristina B. Kooiker, Saswata S. Sarkar, et al.. (2016). Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin. Cell Reports. 17(11). 2857–2864. 61 indexed citations
9.
Spudich, James A., Tural Aksel, Sadie R. Bartholomew, et al.. (2016). Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human β-cardiac myosin. Journal of Experimental Biology. 219(2). 161–167. 55 indexed citations
10.
Sarkar, Saswata S., Jayant B. Udgaonkar, & Guruswamy Krishnamoorthy. (2013). Unfolding of a Small Protein Proceeds via Dry and Wet Globules and a Solvated Transition State. Biophysical Journal. 105(10). 2392–2402. 39 indexed citations
11.
Sarkar, Saswata S., Jayant B. Udgaonkar, & Guruswamy Krishnamoorthy. (2012). Structure and Dynamics of Molten Globular Intermediates Encountered during the Unfolding of Barstar. Biophysical Journal. 102(3). 449a–449a. 1 indexed citations
12.
Sarkar, Saswata S., Jayant B. Udgaonkar, & G. Krishnamoorthy. (2011). Reduced Fluorescence Lifetime Heterogeneity of 5-Fluorotryptophan in Comparison to Tryptophan in Proteins: Implication for Resonance Energy Transfer Experiments. The Journal of Physical Chemistry B. 115(22). 7479–7486. 23 indexed citations
13.
Sarkar, Saswata S., Indira Bhagat, R E Dechert, et al.. (2010). 191 Does Phenobarbital Improve the Effectiveness of Therapeutic Hypothermia in Infants with Hypoxic-Ischemic Encephalopathy?. Pediatric Research. 68. 100–100. 1 indexed citations
14.
Sarkar, Saswata S., et al.. (1994). The alternative fitness sets which preserve allele trajectories: a general treatment.. Genetics. 138(4). 1323–1330. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026